某三级甲等医院2007～2009年“医保”住院患者降糖药应用分析

Analysis on Utilization of Hypoglycemic Drug in Medical Insurance Inpatients in Class A Grade Three Hospital During 2007～2009

目的:评价某三级甲等医院"医保"住院患者降糖药的应用情况及趋势。方法:采用限定日剂量法(DDD),对该医院2007～2009年"医保"住院患者降糖药的应用数据进行统计、分析。结果:该院"医保"住院患者降糖药销售金额逐年增高,2008、2009年分别比上一年度增长14.04%、21.65%;胰岛素类销售金额增长较快;联合用药比率达81.57%,其中二联用药占68.66%。结论:新型降糖药已成市场主流,我国制药企业应加快开发疗效确切、经济安全、利于并发症治疗的药物,以降低医疗费用,节约"医保"资源。

OBJECTIVE： To evaluate the status quo and tendency of utilization of hypoglycemic drugs in medical insurance inpatients. METHODS： DDD was used to analyze the data of utilization of hypoglycemic drugs in medical insurance inpatients in class A grade three hospital during 2007-2009. RESULTS： The consumption sum of hypoglycemic drug used for medical patients increased year by year. The rates of increase were up to 14.04% for 2008 and 21.65% for 2009. The consumption sum of insulin increased rapidly. The rate of drug combination was 81.57% among which the rate of using two-drug was 68.66%. CONCLUSION： The new type of hypoglycemic drugs have become the main drugs in the hypoglycemics market. Domestic drug manufacturers should develop effective, safe, economical and be benefit for the treatment of complication so as to decrease medical costs and save the resources of medical insurance.